Xiaofeng Zheng

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Metabolic Syndrome

Top Venues

Cell death and differentiation

Science signaling

The Journal of biological chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Liming Liao, Ping Yang, Weilong Zhang, Shuyu Yu, Hong-Mei Jing, Xiaofeng Zheng
CD98hc promotes drug resistance in extranodal natural killer/T cell lymphoma through tumor cell-derived small extracellular vesicles. Science signaling 17 (853) (2024)
Min Wei, Xinping Huang, Liming Liao, Yonglu Tian, Xiaofeng Zheng
SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer research (2023)
Jianfeng Fu, Siru Zhou, Huilin Xu, Liming Liao, Hui Shen, Peng Du, Xiaofeng Zheng
ATM-ESCO2-SMC3 axis promotes 53BP1 recruitment in response to DNA damage and safeguards genome integrity by stabilizing cohesin complex. Nucleic acids research (2023)
Xinping Huang, Yan Zhao, Min Wei, Ruipeng Zhuge, Xiaofeng Zheng
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex. Journal of molecular cell biology (2023)
Xinping Huang, Yongfeng Yang, Dan Zhu, Yan Zhao, Min Wei, Ke Li, Hong-Hu Zhu, Xiaofeng Zheng
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As 2 O 3 by stabilizing oncoprotein PML-RARα. Cellular and molecular life sciences : CMLS 79 (6) (2022)
Yan Zhao, Xinping Huang, Dan Zhu, Min Wei, Jiechen Luo, Shuyu Yu, Yonglu Tian, Xiaofeng Zheng
Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. Cell death and differentiation (2022)
Shuyu Yu, Weicheng Zang, Yuchong Qiu, Liming Liao, Xiaofeng Zheng
Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene (2021)
Ruidan Xu, Yongfeng Yang, Xiaofeng Zheng
Unique structural features of the adenylate kinase hCINAP/AK6 and its multifaceted functions in carcinogenesis and tumor progression. FEBS letters 595 (16) (2021)
Dan Zhu, Ruidan Xu, Xinping Huang, Zefang Tang, Yonglu Tian, Jinfang Zhang, Xiaofeng Zheng
Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. Cell death and differentiation 28 (6) (2020)
Shuwen Chen, Yanbin Wang, Liming Liao, Li Meng, Juanjuan Li, Cheng Shi, Hong Jing Han, Xiaofeng Zheng, Huan Shen
Similar Repair Effects of Human Placenta, Bone Marrow Mesenchymal Stem Cells, and Their Exosomes for Damaged SVOG Ovarian Granulosa Cells. Stem cells international 2020 (2020)
Weicheng Zang, Chuanzhen Yang, Tingting Li, Liming Liao, Xiaofeng Zheng
Cellular redox sensor HSCARG negatively regulates the translesion synthesis pathway and exacerbates mammary tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 116 (51) (2019)
Ruidan Xu, Shuyu Yu, Dan Zhu, Xinping Huang, Yuqi Xu, Yimin Lao, Yonglu Tian, Jinfang Zhang, Zefang Tang, Yuanyuan Zhang, Jing Yi, Hong Hu Zhu, Xiaofeng Zheng
hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy. Nature communications 10 (1) (2019)
Liting Zhang, Jin Liu, Liping Qian, Qian Feng, Xiaofang Wang, Yukang Yuan, Yibo Zuo, Qiao Cheng, Ying Miao, Tingting Guo, Xiaofeng Zheng, Hui Zheng
Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome. PLoS pathogens 14 (5) (2018)
Chuanzhen Yang, Weicheng Zang, Yapeng Ji, Tingting Li, Yongfeng Yang, Xiaofeng Zheng
Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response. The Journal of biological chemistry 294 (8) (2018)